Genome Sequencing for Newborn Screening—An Effective Approach for Tackling Rare Diseases
JAMA Network Open · 01.09.2023 · 6 (9) · e2331141
DOI: 10.1001/jamanetworkopen.2023.31141 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Network Open, online erschienen am 01.09.2023. Verfasst von Shan Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Health Development Research Centre, Shanghai, China. Hauptthemen laut MEDLINE: Neonatal Screening, Rare Diseases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
distress.The challenges in affordability and accessibility further underscores the importance of early awareness and interventions targeting rare diseases through genome sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Shanghai Health Development Research Centre, Shanghai, China.
- Macquarie University Centre for the Health Economy, Macquarie Business School and Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Zitieren
APA
Jiang, S., Wang, H., & Gu, Y. (2023). Genome Sequencing for Newborn Screening—An Effective Approach for Tackling Rare Diseases. JAMA Network Open, 6(9), e2331141. https://doi.org/10.1001/jamanetworkopen.2023.31141
Vancouver
Jiang S, Wang H, Gu Y. Genome Sequencing for Newborn Screening—An Effective Approach for Tackling Rare Diseases. JAMA Network Open. 2023;6(9):e2331141. doi:10.1001/jamanetworkopen.2023.31141
BibTeX
@article{Jiang2023,
author = {Jiang, Shan and Wang, Haiyin and Gu, Yuanyuan},
title = {Genome Sequencing for Newborn Screening—An Effective Approach for Tackling Rare Diseases},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {9},
pages = {e2331141},
doi = {10.1001/jamanetworkopen.2023.31141}
}
EUVIMED